Skip to main content
Loading

What are the considerations for successful lead identification & optimization in biotherapeutic antibody discovery?

17 Jun 2024
Salon B
Lead Identification & Optimization
What are the considerations for successful lead identification & optimization in biotherapeutic antibody discovery?
  • Integrated antibody discovery mindset based on biotherapeutic MOA is critical.
  • How to choose lead identification and optimization platforms?
  • You get what you screen for! The importance of screening assays in lead identification & optimization.
  • Assessment of functionality and developability of the lead candidates in parallel at early antibody discovery stage helps select and advance PCC candidate with desired properties.
Industry Expert
Macy Jin, Associate Director - WuXi Biologics